NCT06886490 (VEGPREV) is a NA clinical trial of Mediterranean diet in Obesity and Overweight, sponsored by Medical University of Warsaw.

Who is sponsoring NCT06886490?

NCT06886490 is sponsored by Medical University of Warsaw.

What drugs are being tested in NCT06886490?

Interventions in NCT06886490: Mediterranean diet, Planetary diet, Lactovegetarian diet, Vegan diet, Control diet.

What condition does NCT06886490 study?

NCT06886490 studies Obesity and Overweight, Dietary Intervention, Vegetarian Diet, Vegan Diet, Mediterranean Diet, Metabolic Cardiovascular Syndrome.

Is NCT06886490 still recruiting?

NCT06886490 is currently completed. Last updated 20 March 2025.

Last reviewed 2025-03-20 · How we verify

NCT06886490: VEGPREV

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Plant-based Diets and Body Weight and Selected Metabolic Parameters Management in Obese Patients.

Completed NA Last updated 20 March 2025

What this trial tests

NA trial testing Mediterranean diet in Obesity and Overweight in 90 participants. Completed in 18 December 2024.

Timeline

1 October 2023

Primary endpoint
5 August 2024

18 December 2024

Quick facts

Lead sponsor	Medical University of Warsaw
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	none
Primary purpose	treatment
Enrollment	90
Start date	1 October 2023
Primary completion	5 August 2024
Estimated completion	18 December 2024
Sites	1 location across Poland

Drugs / interventions tested

Mediterranean diet
Planetary diet
Lactovegetarian diet
Vegan diet
Control diet

Conditions studied

Obesity and Overweight — all drugs for Obesity and Overweight →
Dietary Intervention — all drugs for Dietary Intervention →
Vegetarian Diet — all drugs for Vegetarian Diet →
Vegan Diet — all drugs for Vegan Diet →

Sponsor

Medical University of Warsaw

Who can join

Adults 18 to 60, any sex, with Obesity and Overweight or Dietary Intervention. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The aim of the study is to determine the optimal plant-based dietary model in terms of weight loss and health that would be both acceptable and environmentally friendly dietary model based on limiting the consumption of meat and animal products. Such findings will lead to new knowledge and allow us to formulate new principles for the nutritional treatment of people suffering from obesity.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

The VEGPREV study: effectiveness of four plant-based diets on weight loss, metabolic syndrome components and appetitive traits in overweight and obese individuals: a randomized controlled trial.
Wiśniewska K, Okrȩglicka KM, Paskudzka M, Jagielska AM, et al · · 2025 · PMID 41340660 · DOI 10.3389/fnut.2025.1677496

Verify or expand the search:

Other trials of Mediterranean diet

Trials testing the same drug.

NCT07385716 — Evaluation of the Effect of Time-Restricted Feeding and Mediterranean Diet Model in Women With Polycystic Ovary Syndrome · NA · recruiting
NCT07017127 — Remission of Type 2 Diabetes With Lifestyle Intervention · NA · recruiting
NCT07055620 — Effects of Different Dietary Models on Eating Behavior and Obesity Management in Overweight and Obese Individuals · NA · completed
NCT06774079 — Glucagon-like Peptide-1 Receptor Agonist (GLP-1 RA) and Diet in Inflammatory Bowel Disease (IBD) Patients · Phase 4 · recruiting
NCT06765369 — How the Mediterranean Diet Affects You: Predicting Responses Based on Your Microbiome · NA · not yet recruiting

Other recruiting trials for Obesity and Overweight

Currently open trials in the same condition.

NCT06857929 — "Improving Health and Reducing Chronic Disease Risk in Middle-Aged Adults Through Nutrition" · NA · recruiting
NCT06724172 — CHIME: Comparing Health Interventions for Maternal Equity · NA · recruiting
NCT07032545 — Metabotyping of Broccoli Microgreen in Obese Breast Cancer Survivors · NA · recruiting
NCT06768827 — New Mechanisms of Obesity · NA · recruiting
NCT06935838 — Effects of Tirzepatide on Weight Loss and Chronic Inflammation in People With HIV · Phase 2 · recruiting

Other Medical University of Warsaw trials

Trials by the same sponsor.

NCT07515768 — TAVI Without On-Site Cardiac Surgery in Poland: A Randomized Multicenter Trial Protocol · NA · not yet recruiting
NCT07511907 — Routine Intraoperative White Test for Bile Leak Detection in Liver Resection · NA · not yet recruiting
NCT07498660 — PRP Injection Into the Sacroiliac Joint After Ipsilateral THA: Effects on Early Recovery and Function (SIJ-THA Randomize · NA · not yet recruiting
NCT07398898 — Use of Augmented Reality Glasses and Noise-Cancelling Headphones to Reduce Dental Anxiety in Adult Patients · NA · recruiting
NCT07237204 — 15 vs 45 Minute Pringle Maneuver in Liver Cancer Resection: Randomized Noninferiority Trial · NA · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT06886490 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Medical University of Warsaw
Last refreshed: 20 March 2025

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06886490.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing